News
This phase 2b/3 trial follows new, positive 2-year data from the phase 2 ALTITUDE trial, in which sura-vec was well-tolerated ...
MUSCAT: The National Programme for Early Detection of Diabetic Retinopathy using artificial intelligence (AI) technologies ...
New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an ...
The agreement is for a planned clinical trial of AXPAXLI (also known as OTX-TKI) for the treatment of non-proliferative ...
16h
HealthDay on MSNGLP-1 Receptor Agonists May Reduce Complications of Diabetic Retinopathy
GLP-1 receptor agonists linked to modestly increased risk for incident DR, but tied to reduced risk for certain complications of DR.
Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the second quarter ended June 30, 2025.
Drugs such as Ozempic, Wegovy, and Mounjaro (known as semaglutide and tirzepatide) have changed the way clinicians manage ...
A new study shows drugs such as Ozempic come with a small but increased risk of a condition known as an ‘eye stroke’.
22h
Onlymyhealth on MSNNew Study Links Weight Loss Drugs To Optic Nerve Disorders: Here's Everything Diabetes Patients Should Know
As weight loss drugs like Ozempic and Mounjaro gain a lot of attention worldwide a new study has revealed a rare side effect ...
2h
Healthcare Asia Magazine on MSNWhat factors drive the ophthalmology surgical device market?
Eye disorders such as cataracts and glaucoma fuel the sector’s demand. The rising prevalence of vision-related disorders is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results